Advance Search
CHEN Yingzi, MENG Xinlong, DU Peng, MIU Congqing, FAN Aijuan, LIU Jingjing, LU Dechuan. Effect observation of insulin pump combined with dipeptidyl peptidase-Ⅳ inhibitor on the treatment of newly diagnosed type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2019, 23(8): 22-24. DOI: 10.7619/jcmp.201908005
Citation: CHEN Yingzi, MENG Xinlong, DU Peng, MIU Congqing, FAN Aijuan, LIU Jingjing, LU Dechuan. Effect observation of insulin pump combined with dipeptidyl peptidase-Ⅳ inhibitor on the treatment of newly diagnosed type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2019, 23(8): 22-24. DOI: 10.7619/jcmp.201908005
shu

Effect observation of insulin pump combined with dipeptidyl peptidase-Ⅳ inhibitor on the treatment of newly diagnosed type 2 diabetes mellitus

  • Department of Endocrinology, Jiangdu People′s Hospital Affiliated to Medical College of Yangzhou University, Yangzhou, Jiangsu, 225200

More Information
  • Received Date: January 08, 2019
  • Accepted Date: February 07, 2019
  • Available Online: December 03, 2020
  • Published Date: April 27, 2019
    Graphical Abstract
    • Abstract
  •   Objective  To investigate the effect of insulin pump combined with dipeptidyl peptidase-Ⅳ (DPP-Ⅳ) inhibitor on the treatment of newly diagnosed type 2 diabetes mellitus (T2DM).
      Methods  Totally 51 newly diagnosed patients with T2DM were randomly divided into experimental group (insulin pump combined with DPP-Ⅳ inhibitor) and control group (insulin pump alone). After 15 days of treatment, the clinical effect was compared between two groups.
      Results  After treatment, the blood sugar related indexes in both groups significantly improved (P < 0.05), and the blood sugar control of the experimental group was significantly better than that of the control group (P < 0.05). The pancreatic β cell function index, area under curve of C-peptide and insulin resistance index in the experimental group were significantly better than those in the control group (P < 0.05). The dosage of insulin, the ratio of patients with blood sugar reaching the standard completely, the time of blood sugar reaching the standard and the increase value of body mass in the experimental group were significantly better than those in the control group (P < 0.01). The incidence rate of hypoglycemia was 8.00% (2/26) in the experimental group and 12.00% (3/25) in the control group, and there was no significant difference between the two groups (P>0.05). During the treatment, no severe hypoglycemic events and liver and kidney function damage occurred in both groups.
      Conclusion  Insulin pump combined with DPP-Ⅳ inhibitor is effective in the treatment of newly diagnosed T2DM, which can effectively control blood sugar, reduce insulin resistance and weight gain.
    • FullText(HTML)
    • References (9)
  • [1]
    陈灏珠. 内科学[M]. 8版. 北京: 人民卫生出版社, 2013: 1-54.
    [2]
    王凯军, 梅询. 高胰岛素血症与动脉粥样硬化研究现状[J]. 实用临床医学, 2014, 9(10): 129-130. https://www.cnki.com.cn/Article/CJFDTOTAL-KDYZ201301015.htm
    [3]
    邢莉, 申虎威. 地特胰岛素加三餐前速效胰岛素与胰岛素泵短期强化治疗对2型糖尿病的疗效比较[J]. 中国糖尿病杂志, 2012, 20(2): 126-128. doi: 10.3969/j.issn.1006-6187.2012.02.012
    [4]
    Ismail-Beigi F. Pathogenesis and glycemic management of type 2 diabetes mellitus: a physiological approach[J]. Arch Iran Med, 2012, 15(4): 239-246. http://www.ncbi.nlm.nih.gov/pubmed/22424044
    [5]
    谢艳红, 莫朝晖, 金萍, 等. 初诊2型糖尿病短期胰岛素强化治疗后胰岛β细胞功能的动态变化[J]. 中国糖尿病杂志, 2008, 16(4): 225-227. doi: 10.3321/j.issn:1006-6187.2008.04.010
    [6]
    陆浩, 钱菊英, 葛均波. 高胰岛素血症与型糖动脉粥样硬化[J]. 中国临床医学, 2008, 15(1): 35-38. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX200801013.htm
    [7]
    Müller W A, Faloona G R, Aguilar-Parada E, et al. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion[J]. N Engl J Med, 1970, 283(3): 109-115. doi: 10.1056/NEJM197007162830301
    [8]
    Wajchenberg B L. beta-cell failure in diabetes and preservation by clinical treatment[J]. Endocr Rev, 2007, 28(2): 187-218. http://www.ncbi.nlm.nih.gov/pubmed/17353295
    [9]
    占美, 徐班, 吴逢波. 沙格列汀治疗2型糖尿病的Meta分析[J]. 中国循证医学杂志, 2012, 12(6): 708-710. doi: 10.3969/j.issn.1672-2531.2012.06.016
    • Related Articles

  • Related Articles

    [1]GONG Xiaoyong, HU Xiaowei, HE Fei, HU Jianping. Correlations between serum levels of brain natriuretic peptide, hypersensitive C-reactive protein as well as creatine kinase isoenzyme and prognosis of patients after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 72-76. DOI: 10.7619/jcmp.20211053
    [2]CHEN Gang. Correlation between resting heart rate and serum high sensitive C reactive protein, brain natriuretic peptide and left ventricular ejection fraction in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2019, 23(24): 31-33, 36. DOI: 10.7619/jcmp.201924010
    [3]GAO Zhangdai, WU Bin, QI Lijun, ZHENG Xiyuan. Relationship between serum B-type natriuretic peptide, D-dimer, C reactive protein and short-termprognosis in patients with massive cerebral infarction in subacute phase[J]. Journal of Clinical Medicine in Practice, 2019, 23(14): 32-35. DOI: 10.7619/jcmp.201914008
    [4]XU Kui, WANG Zhongsan, CHEN Min, HE Bo. Effect of mean arterial pressure variability on N-terminal brain natriuretic peptide precursor and high-sensitivity C-reactive protein during internal fixation of lower limb fractures in the elderly patients[J]. Journal of Clinical Medicine in Practice, 2019, 23(11): 106-108, 112. DOI: 10.7619/jcmp.201911030
    [5]XIN Suping, ZHOU Jiaojiao, DONG Ru, SHAO Xuejing. Correlation between serum cystatin C level and different body mass index in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2018, (11): 75-78. DOI: 10.7619/jcmp.201811021
    [6]WU Hongli, TIAN Ruixue, YE Qing, SONG Yujia. Expressions of brain natriuretic peptide, fibrinogen,hypersensitive C-reactive protein, D-Dimer and arterial blood gas analysis in acute exacerbation of chronic obstructive pulmonary disease patients complicated with pulmonary hypertension[J]. Journal of Clinical Medicine in Practice, 2018, (3): 31-33,37. DOI: 10.7619/jcmp.201803008
    [7]MA Shufang, DU Zhipo, WANG Yunxing, WANG Yuxiao, HOU Bingjie. Effects of different hypoglycemic treatments on glucagon-like peptide-1 and its correlation with β cells function in newly diagnosed type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2017, (19): 56-58. DOI: 10.7619/jcmp.201719016
    [8]TANG Yuanyuan, HOU Xiaofeng, WANG Yao, ZOU Jiangang. Correlation between serum N-terminal pro-brain natriuretic peptide, serum cystatin C and left ventricular remodeling in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2015, (24): 59-62. DOI: 10.7619/jcmp.201524018
    [9]FU Pan, LI Chunbi. Clinical significance of high sensitivity C reactive protein detection and brain natriuretic peptide detection in treatment of patients with chronic obstructive pulmonary disease combined with pulmonary heart disease[J]. Journal of Clinical Medicine in Practice, 2015, (1): 29-31,48. DOI: 10.7619/jcmp.201501009
    [10]ZHOU Hualan, HU Youdong, GUO Dianxuan, LI Xia, XU Peijing. Relationship between adiponectin,B-type natriuretic peptide,high sensitivity C-reactive protein and cardiac function classification in patients with degenerative heart valvular disease[J]. Journal of Clinical Medicine in Practice, 2014, (16): 25-27. DOI: 10.7619/jcmp.201416007

  • Cited by

    Periodical cited type(8)

    1. 金珍琳，金婷，庄强. 艾曲泊帕治疗原发免疫性血小板减少症患者的回顾性研究. 中国现代医生. 2024(11): 69-72 .
    2. 马丽，包萃华. TPO受体激动剂在难治性原发免疫性血小板减少症中的研究进展. 内蒙古医学杂志. 2024(07): 927-930+934 .
    3. 李亮，卞建军，苏玉璇，沈磊，傅磊. 海曲泊帕乙醇胺片联合环孢素A治疗难治性免疫性血小板减少症的临床疗效及安全性. 现代生物医学进展. 2024(24): 4695-4699 .
    4. 袁文志. 艾曲泊帕联合环孢素治疗原发性血小板减少症的临床疗效分析. 中外医疗. 2024(34): 82-85 .
    5. 梅婷，孙小力，齐淑静，魏广祎. 自拟益气健脾解毒化瘀方联合艾曲泊帕治疗恶性肿瘤化疗相关性血小板减少症的临床效果. 临床误诊误治. 2023(06): 138-142 .
    6. 胡星月，赵彤，张思源，乐丽霞，宋朋飞，李洁. 联合用药治疗成人原发免疫性血小板减少症. 中国医药科学. 2023(14): 45-48+85 .
    7. 张潇，回广飞，任天舒，许子华，周春娟，王艳帅，赵俭. 异基因造血干细胞移植患者环孢素血药浓度及影响因素分析. 临床军医杂志. 2022(09): 926-929 .
    8. 周林，禹红，万敏，刘毓玲，段波，王进军. 芪黄汤对免疫性血小板减少症小鼠作用机制研究. 临床军医杂志. 2022(09): 975-977 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (293) PDF downloads (6) Cited by(9)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return